Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Healthcare Cannabis Psychedelics
Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.


TSXV:DHB - Post by User

Delivra Health Brands Inc
Bullboard Posts
User Avatar Image
(6)
•••
Comment by Toptenconceptson May 18, 2019 9:00pm
179 Views
Post# 29759039

RE:Q3 2019

RE:Q3 2019
Cashmeoutside wrote: About 7 business days until their next financial quarter release. 6 million revenue would be a nice growth value at about 50% increase from Q2. What are your predictions?

S

i think 5.5 would be really good.. the pills and other deals along with dva won’t have a full quarter till Q4 and Q1.. which I think Q1 they will actually be making money..so 5.5 is good .. but Q4 could be 10 million ...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities